Company / Total Debt
Sonoma Pharmaceuticals, Inc. Total Debt History
FY2017-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Debt
-
FY2022
5-year range
$0 / $0
FY2018-FY2022
Trend
-100.0%
vs FY2021
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Remained stable around $0 over the past 2 years.
Total Debt over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2022, total debt decreased 100.0% year-over-year.
- Peak total debt was recorded in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total DebtValue | YoY GrowthYoY |
|---|---|---|
| FY2026 | - | - |
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | $0 | -100.0% |
| FY2021 | $1.3M | - |
| FY2020 | $0 | -100.0% |
| FY2019 | $12.0K | -62.5% |
| FY2018 | $32.0K | -28.9% |
| FY2017 | $45.0K | - |
As of FY2022 · SEC 10-K · Updated Jun 28, 2026